mda-mb-468 glutathione content Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics | Cancer Cell International MDA-MB-468 (DMEM) Cell Complete Medium
MDA MB 468 (DMEM) Cell Complete Medium MDA MB 468 Xenograft Model Altogen Labs Frontiers Formononetin triggers ferroptosis in triple negative breast cancer cells by regulating the mTORC1 SREBP1 SCD1 pathway Frontiers Dihydroartemisinin Transferrin Adducts Enhance TRAIL Induced Apoptosis in Triple Negative Breast Cancer in a P53 Independent and ROS Dependent Manner RSL3 induces ferroptosis by activating the NF B signalling pathway to enhance the chemosensitivity of triple negative breast cancer cells to paclitaxel Scientific Reports MDA MB 468 HTB 132 ATCC
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14




